Androxal
Hypogonadotropic Hypogonadism
Repros Therapeutics Inc.Phase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Hypogonadotropic Hypogonadism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TESTOSTERONE UNDECYLATE Canisius-Wilhelmina Hospital | Phase 4 | A |
Metformin University Medical Centre Ljubljana | Phase 4 | BBB |
Arimidex Baylor College of Medicine | Phase 4 | BBB |
Liraglutide University Medical Centre Ljubljana | Phase 4 | BB |
Testim Odense University Hospital | Phase 4 | BB |
View all 22 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →